AroCell AB AROC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 0.38
- Day Range
- SEK 0.37–0.38
- 52-Week Range
- SEK 0.30–0.70
- Bid/Ask
- SEK 0.37 / SEK 0.38
- Market Cap
- SEK 87.31 Mil
- Volume/Avg
- 46,652 / 170,345
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.02
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 26
- Website
- https://www.arocell.com
Valuation
|
Metric
|
AROC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.53 |
Price/Sales | 2.02 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
AROC
|
|---|---|
Quick Ratio | 5.20 |
Current Ratio | 5.79 |
Interest Coverage | −4,598.77 |
Quick Ratio
AROC
Profitability
|
Metric
|
AROC
|
|---|---|
Return on Assets (Normalized) | −26.63% |
Return on Equity (Normalized) | −28.08% |
Return on Invested Capital (Normalized) | −28.21% |
Return on Assets
AROC
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Fpqflmhpwt | Grh | $209.3 Bil | |
DHR
| Danaher Corp | Zntmxhhht | Bxlgbj | $174.8 Bil | |
IQV
| IQVIA Holdings Inc | Pwwscntl | Zfyjhx | $41.3 Bil | |
IDXX
| IDEXX Laboratories Inc | Pwlxnwqjg | Rppzvr | $39.6 Bil | |
A
| Agilent Technologies Inc | Xvcbytlfpc | Vmtj | $39.2 Bil | |
MTD
| Mettler-Toledo International Inc | Bpfgjwbpmz | Ldhyzqw | $25.5 Bil | |
ICLR
| Icon PLC | Bmrhmhkc | Ncgtff | $24.6 Bil | |
ILMN
| Illumina Inc | Mxrwgfhl | Pdhmbk | $18.6 Bil | |
WAT
| Waters Corp | Knfcsjbhlb | Dryz | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Qykvyhhvj | Ylmkgk | $17.1 Bil |